PETER JINDRA to Treatment Outcome
This is a "connection" page, showing publications PETER JINDRA has written about Treatment Outcome.
Connection Strength
0.179
-
Genetic Polymorphism in Cytokines and Costimulatory Molecules in Stem Cell and Solid Organ Transplantation. Clin Lab Med. 2019 03; 39(1):107-123.
Score: 0.049
-
Prognostic factors to predict outcome of reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukemia. Neoplasma. 2016; 63(4):595-600.
Score: 0.040
-
The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: an analysis of 96 allografted AML patients = 50 years from the Czech acute leukaemia clinical register (alert). Neoplasma. 2013; 60(5):576-83.
Score: 0.033
-
Soluble mesothelin-related peptide as a prognosticator in pleural mesothelioma patients receiving checkpoint immunotherapy. J Thorac Cardiovasc Surg. 2025 Apr; 169(4):1082-1095.e4.
Score: 0.018
-
Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma. JCI Insight. 2018 04 05; 3(7).
Score: 0.012
-
Pediatric Liver Transplantation Across the ABO Blood Group Barrier: Is It an Obstacle in the Modern Era? J Am Coll Surg. 2016 Apr; 222(4):681-9.
Score: 0.010
-
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2014 Mar; 49(3):389-96.
Score: 0.009
-
A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality. Bone Marrow Transplant. 2014 Mar; 49(3):376-81.
Score: 0.009